品茶2025工作室,51一品茶楼论坛,51论坛一品楼

Recently, Xiamen Humanity Hospital and Neuboron have completed enrollment for the BNCT (Phase I) registered clinical trials, with the Phase II registered clinical trial research now fully underway. This marks a significant milestone in China's BNCT advancement, paving the way into a new era.

Since the launch of clinical trials, Xiamen Humanity Hospital has conducted over 70 BNCT clinical research treatments. The successful enrollment in Phase I trials established China’s first BNCT registered clinical database for domestic populations, filling a gap in this field domestically. By closely integrating the collection of subjects’ actual clinical characteristics, it has yielded invaluable clinical data encompassing larger cohorts and diverse case profiles, contributing the Chinese approach to global oncology therapies.